BlackRock Fund Advisors - PROTEON THERAPEUTICS INC ownership

PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 49 filers reported holding PROTEON THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of PROTEON THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$44,000
-78.9%
23,115
+3.4%
0.00%
Q3 2016$209,000
+16.1%
22,361
-0.3%
0.00%
Q2 2016$180,000
-88.0%
22,431
-88.4%
0.00%
Q1 2016$1,498,000
-52.8%
193,508
-5.4%
0.00%
-100.0%
Q4 2015$3,174,000
+14.5%
204,638
+2.7%
0.00%0.0%
Q3 2015$2,771,000
-19.7%
199,223
+3.1%
0.00%0.0%
Q2 2015$3,451,000193,2030.00%
Other shareholders
PROTEON THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Abingworth LLP 2,017,872$27,423,00016.02%
Monashee Investment Management LLC 77,102$1,072,0007.40%
Deer VII & Co. Ltd. 315,101$4,383,0004.15%
RA Capital Management 1,506,872$20,961,0003.01%
MPM ASSET MANAGEMENT LLC 983,381$13,679,0002.10%
Omega Fund Management, LLC 250,000$3,478,0001.96%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,265,343$17,601,0000.68%
Perceptive Advisors 550,000$7,650,0000.31%
TIVERTON ASSET MANAGEMENT LLC 375,000$5,216,0000.12%
Baker Brothers Advisors 274,617$3,820,0000.04%
View complete list of PROTEON THERAPEUTICS INC shareholders